Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-Current DebtOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Cash: 2019-2025

Historic Change in Cash for Legend Biotech (LEGN) over the last 5 years, with Mar 2025 value amounting to $153.6 million.

  • Legend Biotech's Change in Cash rose 140.43% to $153.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$455.5 million, marking a year-over-year decrease of 293.98%. This contributed to the annual value of -$988.9 million for FY2024, which is 301.40% down from last year.
  • As of Q1 2025, Legend Biotech's Change in Cash stood at $153.6 million, which was up 190.19% from -$170.3 million recorded in Q4 2024.
  • Legend Biotech's 5-year Change in Cash high stood at $570.8 million for Q2 2023, and its period low was -$696.3 million during Q2 2024.
  • Its 3-year average for Change in Cash is -$38.3 million, with a median of -$123.6 million in 2023.
  • As far as peak fluctuations go, Legend Biotech's Change in Cash skyrocketed by 5,867.42% in 2021, and later slumped by 221.99% in 2024.
  • Quarterly analysis of 5 years shows Legend Biotech's Change in Cash stood at $350.5 million in 2021, then tumbled by 107.30% to -$25.6 million in 2022, then spiked by 1,322.17% to $312.8 million in 2023, then plummeted by 154.43% to -$170.3 million in 2024, then surged by 140.43% to $153.6 million in 2025.
  • Its last three reported values are $153.6 million in Q1 2025, -$170.3 million for Q4 2024, and $257.5 million during Q3 2024.